Rapamycin for Skin

Besides An Essential Skin Care Ingredient, Rapamycin Can Do More!

• 2024-02-19
  

  Unveiling the Next Breakthrough in Anti-Aging: The Promising Frontier

  2. Rapamycin: Initially approved for immunosuppression, rapamycin has demonstrated promising effects in combating age-related diseases, improving overall health, and extending the lifespan of animals. Ongoing clinical trials aim to determine its efficacy in humans as an anti-aging intervention.
• 2023-05-04
  

  Analysis of 70 macrocyclic drugs approved by the FDA

  In addition to this, there are several macrocyclic drugs that act as molecular gums, forming ternary complexes with protein targets. "The combination of cyclosporine and wolrosporine with cyclophilin A(CyPA) and neurocalcin B(CNB) is used in the treatment of autoimmune diseases and in immunosuppression to prevent transplant organ rejection." Fk506-binding protein FKBP12 in ternary complexes with CNB or mammalian target of rapamycin (mTOR), induced by macroloops of ascomycin and the rapamycin family, is used in autoimmune diseases, immunosuppression, and oncology.
  macrocyclic
• 2023-04-06
  

  In the 'internal roll' neural intervention track innovation breakthrough, 3 stenosis ischemia products support more than 100 million revenue

  Sanol has independently developed the world's first NOVA drug-eluting stent for the treatment of intracranial stenosis. The NOVA scaffold is a flexible, thin-wall stainless steel scaffold with an open-loop design and a composite surface of an electron graft substrate and a biodegradable drug coating of rapamycin. The scaffold reaches the lesion site through its rapid exchange balloon catheter delivery system, providing anti-proliferation, accurate positioning, good adherence to the wall, and low incidence of recenosis.
  neurointerventional instruments
• 2023-02-01
  

  Anti-aging drugs, saving 3 years stolen by the new crown

  Rapamycin, a compound first isolated from bacteria in the soil of Easter Island in 1960, inhibits mammalian target rapamycin (mTOR) activity. Studies have shown that such drugs can extend the lifespan of mice by 9%-14%, and are classic targets in anti-aging drugs.
  pharmaceutical trend
• 2022-06-21
  

  Top 10 Most Common Drugs For The Treatment Of Breast Cancer

  2. Everolimus: Everolimus is amultifunctional mammalian target of rapamycin (mTOR) inhibitor, and mTOR is anintracellular serine/threonine kinase and is an intracellular centralregulator. Changes in intracellular growth factors and nutrient energy signalscan be sensed.
  anti-virus
• 2022-06-21
  

  What Is The Worst Virus In The World?

  2. Everolimus: Everolimus is amultifunctional mammalian target of rapamycin (mTOR) inhibitor, and mTOR is anintracellular serine/threonine kinase and is an intracellular centralregulator. Changes in intracellular growth factors and nutrient energy signalscan be sensed.
  anti cancer therapy